Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Cardiac stunning in the clinic: the full picture Pomblum VJ; Korbmacher B; Cleveland S; Sunderdiek U; Klocke RC; Schipke JDInteract Cardiovasc Thorac Surg 2010[Jan]; 10 (1): 86-91Cardiac stunning refers to different dysfunctional levels occurring after an episode of acute ischemia, despite blood flow is near normal or normal. The phenomenon was initially identified in animal models, where it has been very well characterized. After being established in the experimental setting, it remained unclear, whether a similar syndrome occurs in humans. In addition, it remained controversial, whether stunning was of any clinical relevance as it is spontaneously reversible. Hence, many studies continue to focus on the properties and mechanisms of stunning, although therapies seem more relevant for attenuating and treating myocardial ischemia/reperfusion (I/R) injury, i.e. to bridge until recovery. This article reviews the different facets of cardiac stunning, i.e. myocardial, vascular/microvascular/endothelial, metabolic, neural/neuronal, and electrical stunning. This review also displays where these facets exist and which clinical relevance they might have. Particular attention is directed to the different therapeutic interventions that the various facets of this I/R-induced cardiac injury might require. A final outlook considers possible alternatives to further reduce the detrimental consequences of brief episodes of ischemia and reperfusion.|*Heart-Assist Devices[MESH]|*Ischemic Preconditioning, Myocardial[MESH]|Animals[MESH]|Cardiovascular Agents/*therapeutic use[MESH]|Combined Modality Therapy[MESH]|Endothelium, Vascular/drug effects/physiopathology[MESH]|Heart Conduction System/drug effects/physiopathology[MESH]|Humans[MESH]|Myocardial Reperfusion Injury/physiopathology/*therapy[MESH]|Myocardial Stunning/physiopathology/*therapy[MESH]|Sympathetic Nervous System/drug effects/physiopathology[MESH]|Treatment Outcome[MESH] |